← The Wire
SRRKNasdaq
Scholar Rock Holding Corp
Biological Products, (No Diagnostic Substances) · DE · CIK 1727196
Develops novel antibodies targeting growth factors for rare neuromuscular diseases
$5.29B
Market cap
$54.96
Last close
+0.4%
1D
+11.7%
5D
2.1M
Volume
Price · last 39 sessions+18.2%
May 4L $43.80 · H $54.96Jun 29
180
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 5, 202610-Q10-QMay 7, 20268-KResults of Operations · Reg FD DisclosureMay 7, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 20268-KReg FD Disclosure · Company UpdateMar 31, 20268-K/AResults of Operations · Reg FD DisclosureMar 3, 202610-K10-KMar 3, 20268-KResults of Operations · Reg FD DisclosureMar 3, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KCompany UpdateDec 2, 20258-KCompany UpdateNov 14, 2025424B5424B5Nov 14, 202510-Q10-QNov 14, 20258-KResults of Operations · Reg FD DisclosureNov 14, 20258-KCompany UpdateOct 14, 20258-KReg FD Disclosure · Company UpdateSep 23, 202510-Q10-QAug 6, 20258-KResults of Operations · Reg FD DisclosureAug 6, 20258-KReg FD Disclosure · Company UpdateJun 18, 20258-KAuditor ChangeJun 3, 20258-KShareholder VoteMay 23, 202510-Q10-QMay 14, 20258-KResults of Operations · Reg FD DisclosureMay 14, 2025DEFA14ADEFA14AMay 12, 20258-KAuditor ChangeMay 12, 2025DEFA14ADEFA14AApr 28, 20258-KExecutive Change · Reg FD DisclosureApr 28, 2025DEFA14ADEFA14AApr 11, 2025DEF 14ADEF 14AApr 11, 20258-KExecutive ChangeMar 21, 202510-K10-KFeb 27, 20258-KResults of Operations · Reg FD DisclosureFeb 27, 20258-KExecutive Change · Reg FD DisclosureJan 29, 20258-KReg FD DisclosureJan 14, 20258-KCompany UpdateJan 13, 202510-Q10-QNov 12, 20248-KResults of Operations · Company UpdateNov 12, 20248-KMaterial Agreement · Company UpdateOct 10, 2024424B5424B5Oct 9, 2024424B5424B5Oct 7, 20248-KReg FD Disclosure · Company UpdateOct 7, 20248-KResults of Operations · Company UpdateAug 8, 202410-Q10-QAug 8, 20248-KSecurity-Holder Rights · Bylaw AmendmentJun 28, 20248-KReg FD Disclosure · Company UpdateJun 24, 20248-KReg FD Disclosure · Company UpdateJun 3, 20248-KMaterial Agreement · Reg FD DisclosureMay 22, 20248-KMaterial AgreementMay 14, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 202410-K10-KMar 19, 20248-KResults of OperationsMar 19, 20248-KExecutive ChangeFeb 15, 2024SC 13GSCHEDULE 13GFeb 14, 2024SC 13GSC 13GJan 26, 20248-KResults of Operations · Reg FD DisclosureJan 8, 202410-Q10-QNov 7, 20238-KResults of Operations · Company UpdateNov 7, 20238-KMaterial Agreement · Company UpdateOct 12, 2023424B5424B5Oct 12, 2023424B5424B5Oct 11, 20238-KReg FD Disclosure · Company UpdateOct 11, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KReg FD Disclosure · Company UpdateJun 30, 20238-KShareholder VoteJun 22, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF 14AMay 1, 20238-KExecutive ChangeApr 10, 20238-KReg FD DisclosureMar 13, 20238-KResults of OperationsMar 7, 202310-K10-KMar 7, 2023SC 13DSC 13DFeb 14, 20238-KReg FD Disclosure · Company UpdateJan 9, 202310-Q10-QNov 14, 2022
Insider Activity
In the 90 days to Feb 23, 2026: 9 sold $15.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 7,427 | $46.94 | $349K |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 857 | $47.86 | $41K |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 200 | $48.48 | $10K |
| Feb 17, 2026 | Ho JunlinGENERAL COUNSEL | Sell | 9,580 | $46.53 | $446K |
| Feb 17, 2026 | Parlavecchio CarynCHRO | Sell | 9,035 | $46.53 | $420K |
| Feb 17, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 7,989 | $46.53 | $372K |
| Feb 17, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sell | 4,157 | $46.53 | $193K |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 12,779 | $46.85 | $599K |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 2,119 | $45.87 | $97K |
| Jan 16, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 8,406 | $44.48 | $374K |
| Jan 16, 2026 | Ho JunlinGENERAL COUNSEL | Sell | 8,016 | $44.48 | $357K |
| Jan 16, 2026 | Parlavecchio CarynCHRO | Sell | 6,600 | $44.48 | $294K |
| Jan 16, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sell | 5,798 | $44.48 | $258K |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sell | 13,112 | $45.20 | $593K |
| Jan 13, 2026 | Hallal DavidChief Executive Officer | Sell | 57,450 | $42.70 | $2.5M |
| Jan 13, 2026 | Vaishnaw AkshayPresident of R&D | Sell | 20,438 | $42.70 | $873K |
| Jan 13, 2026 | Sinha VikasChief Financial Officer | Sell | 16,755 | $42.70 | $715K |
| Jan 13, 2026 | Woods KeithChief Operating Officer | Sell | 16,746 | $42.70 | $715K |
| Dec 16, 2025 | Peng KatieDirector | Sell | 726 | $43.88 | $32K |
| Dec 16, 2025 | Peng KatieDirector | Sell | 280 | $44.63 | $12K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance